LLY · 10-Q · 2026Q2 · Full report
Manufacturing capacity expansion
ELI LILLY & Co · 2026-08-05 · Importance 40 · Surprise 42 · In source text
Lilly has undertaken significant manufacturing expansion initiatives to support anticipated demand for current and prospective incretin products. The company expects additional capacity to become operational over the next several years. It is also investing in global facilities to manufacture existing and future products, resulting in meaningfully higher capital expenditures in the near term.
Key facts
- To support anticipated demand for current and prospective products, the company has undertaken significant manufacturing expansion initiatives and additional capacity is expected to become operational over the next several years. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | probable | — | To support anticipated demand for current and prospective products, the company has undertaken significant manufacturing expansion… |
| assets | positive | probable | — | To support anticipated demand for current and prospective products, the company has undertaken significant manufacturing expansion… |